- Tytuł:
- Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Neurology May 2022 21(5):417-427
Czasopismo naukowe